Background: D-dimer is a reliable and sensitive index of fibrin deposition and stabilization. It is well known that D-dimer levels are significantly associated with cardioembolic infarction and are elevated during the acute phase of cerebral infarction. Several studies also suggest a possible role of D-dimer in the early prognosis of ischemic stroke. However, it is controversial whether D-dimer can also predict the long-term outcome following ischemic stroke. Therefore, the purpose of this study is to investigate the effect of plasma D-dimer level at admission on long-term functional outcome after ischemic stroke. Methods: We recruited 246 patients with acute ischemic stroke. All subjects had their plasma D-dimer levels evaluated and checked by the modified Rankin scale (mRS) at discharge and at follow-up visits at 3 months, 6 months, and 9 months later. All subjects were divided into 4 groups according to mRS (mRS ≤2 vs mRS ≥3) and plasma D-dimer level (< 0.5 µg/ml vs ≥0.5 µg/ml) to investigate the relationship between plasma D-dimer levels and long-term functional outcome in patients with acute ischemic stroke. Results: There are no significant differences of age, gender and stroke risk factors among the 4 groups. The two patient groups with mRS ≥3 showed significant differences according to their plasma D-dimer levels. On the other hand, the two patient groups with mRS≤2 showed no significant differences according to their plasma D-dimer levels. Conclusion: We assume through this study that D-dimer levels play a role in long-term functional neurological outcome in ischemic stroke with severe neurological deficit. However, to clarify the role of D-dimer in stroke, future longitudinal studies involving a large cohort are required. J Neurocrit Care 2015;8(2):85-90
. Comparison of mean value of mRS at discharge, 3-month, 6-month and 9-month follow-up visit between Group 1 and Group 2. The bar graph with the error bars represents the mean value of mRS and the associated 95% CI of the mean. A MannWhitney U-test comparing mean value of mRS at 4 times showed no differences between two groups. mRS: modified Rakin Scale; Group 1 is defined as subject group with mRS≤2 and d-dimer levels < 0.5 µg/mL; Group 2 is defined as subject group with mRS≤2 and d-dimer levels ≥ 0.5 µg/mL. Group 1 is defined as subject group with d-dimer levels < 0.5 µg/mL. Group 2 is defined as subject group with d-dimer levels ≥ 0.5 µg/mL. Data are presented as either mean ± standard deviation or number.
4L에서 모두 의미 있는 차이를 보이지 않았으나 퇴원 후 9개
월 mRS에서는 Group 3은 3.08±1.31, Group 4는 3.62±1.38로
통계적으로 의미있는 차이를 보였다(P=0.039, Fig. 2 ). 이외 다 른 변수에 대해서는 차이를 보이지 않았다 (Table 3) . A Mann-Whitney U-test comparing mean value of mRS at discharge, 3-month and 6-month follow-up visit showed no differences between two groups. However, a significant difference of mean mRS at 9-month follow-up visit was observed between two groups (*P < 0.039). mRS: modified Rakin Scale; Group 3 is defined as subject group with mRS ≥ 3 and d-dimer levels < 0.5 µg/mL; Group 4 is defined as subject group with mRS ≥ 3 and ddimer levels ≥ 0.5 µg/mL. 
